-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOXCEL THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENTS IN U.S. DEPARTMENT OF WAR-FUNDED STUDY OF BXCL501 (SUBLINGUAL DEXMEDETOMIDINE) FOR TREATMENT OF ACUTE STRESS REACTIONS

Reuters·04/08/2026 11:00:02

Please log in to view news